19-19147124-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001145785.2(MEF2B):c.453C>A(p.Gly151=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00585 in 1,604,790 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0044 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 31 hom. )
Consequence
MEF2B
NM_001145785.2 synonymous
NM_001145785.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.91
Genes affected
MEF2B (HGNC:6995): (myocyte enhancer factor 2B) The product of this gene is a member of the MADS/MEF2 family of DNA binding proteins. The protein is thought to regulate gene expression, including expression of the smooth muscle myosin heavy chain gene. This region undergoes considerable alternative splicing, with transcripts supporting two non-overlapping loci (GeneID 729991 and 100271849) as well as numerous read-through transcripts that span both loci (annotated as GeneID 4207). Several isoforms of this protein are expressed from either this locus or from some of the read-through transcripts annotated on GeneID 4207. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 19-19147124-G-T is Benign according to our data. Variant chr19-19147124-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 788835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.91 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 31 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MEF2B | NM_001145785.2 | c.453C>A | p.Gly151= | synonymous_variant | 5/9 | ENST00000424583.7 | |
BORCS8-MEF2B | NR_027308.2 | n.919C>A | non_coding_transcript_exon_variant | 9/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MEF2B | ENST00000424583.7 | c.453C>A | p.Gly151= | synonymous_variant | 5/9 | 5 | NM_001145785.2 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00441 AC: 671AN: 152208Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
671
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00416 AC: 951AN: 228342Hom.: 2 AF XY: 0.00399 AC XY: 496AN XY: 124286
GnomAD3 exomes
AF:
AC:
951
AN:
228342
Hom.:
AF XY:
AC XY:
496
AN XY:
124286
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00600 AC: 8715AN: 1452464Hom.: 31 Cov.: 32 AF XY: 0.00586 AC XY: 4233AN XY: 721992
GnomAD4 exome
AF:
AC:
8715
AN:
1452464
Hom.:
Cov.:
32
AF XY:
AC XY:
4233
AN XY:
721992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00441 AC: 671AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.00392 AC XY: 292AN XY: 74478
GnomAD4 genome
AF:
AC:
671
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
292
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | BORCS8-MEF2B: BP4, BP7; MEF2B: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at